WuXi PharmaTech Reports EPS of $0.28 vs. $0.21

WuXi PharmaTech (Cayman) Inc. WX today announced its financial results for fourth-quarter and full-year 2010.

Net revenues grew 20% year over year to $88.6 million

Non-GAAP diluted earnings per ADS grew 29% year over year to 28 cents

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!